Submit Article
Back to Journal

SM Case Reports

Cefepime Neurotoxicity in a Patient Undergoing Hemodialysis: A Case Report

[ ISSN : 2473-0688 ]

Abstract
Details

Received: 23-Jan-2018

Accepted: 30-Jan-2018

Published: 05-Feb-2018

Case Report | Volume 4 - Issue 1 | Article DOI :

Download PDF

Aynur Atilla¹*, Banu Ramazanoğlu², Özgür Günal¹, and Sırrı Kiliç¹

¹Department of Infectious Diseases and Clinical Microbiology, Samsun Training and Research Hospital, Turkey

²Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University Faculty of Medicine, Turkey

Corresponding Author:

Aynur Atilla, Department of Infectious Diseases and Clinical Microbiology, Samsun Training and Research Hospital, Samsun, Turkey, Tel: 00905325568767; Email: aynur.atilla@gmail.com

Keywords

Cefepime; Beta-lactam neurotoxicity; Chronic renal failure

Abstract

Neurotoxicity is a rare complication of cephalosporin therapy. This side effect has been reported mainly in patients with renal insufficiency. Patients with chronic renal failure treated with cefepime can be more sensitive to neurotoxicity despite dose adjustment. We report a 65-year-old male patient who underwent hemodialysis treated with cefepime who experienced neurotoxicity while receiving adjusted dose cefepime.

Citation

Atilla A, Ramazano?lu B, Günal Ö and Kiliç SS. Cefepime Neurotoxicity in a Patient Undergoing Hemodialysis: A Case Report. SM J Case Rep. 2018; 4(1): 1078.